바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

Management of Chronic Kidney Disease in Obesity Patients

Archives of Obesity and Metabolism / Archives of Obesity and Metabolism, (P)2951-0333; (E)2951-0597
2022, v.1 no.2, pp.66-73
https://doi.org/10.23137/AOM22.02.RA0008
Kunhee Han (Department of Family Medicine, Seoul Medical Center, Seoul, Korea)
  • Downloaded
  • Viewed

Abstract

Obesity is an increasing public health and medical issue worldwide. It has been associated with several comorbidities, including diabetes, cardiovascular disease, stroke, and cancer. Chronic kidney disease (CKD) is another important comorbidity of obesity. Other major causes of CKD include hypertension and diabetes. However, the association between obesity and CKD is often overlooked. Among patients with CKD, patients with obesity were more vulnerable to have rapid kidney function decline than that of those with normal weight. Additionally, CKD is more prevalent among patients with obesity. These aggravations are induced through multiple mechanisms, specifically metabolic impairment of obesity and mechanical burden because of increasing intraabdominal renal pressure. Furthermore, the inflammation and lipotoxicity, caused by obesity, are critical in the CKD aggravation in patients with obesity. To prevent this, all adult patients with obesity are tested for CKD. The workup includes the estimated glomerular filtration rate and regular follow-up. Step-wise management is required for patients with obesity with CKD. Prompt reduction and management of obesity effectively delay CKD progression among patients with obesity and CKD. Therefore, weight loss is a core management for patients with obesity and CKD. Based on several studies, this article focused on the association between CKD and obesity, as well as the diagnosis and weight management of patients with obesity and CKD.

keywords
Renal insufficiency, Chronic, Obesity, Anti-obesity agents, Glomerular filtration rate, Bariatric surger

Archives of Obesity and Metabolism